Stock Price & Analysis

Based on the analysis of EPAM Systems, Inc. (EPAM), here is the recommendation:

Buy
EPAM stock is a buy due to strong earnings, a "Moderate Buy" analyst consensus, and potential upside of 24%-42.5%. However, consider the technical setup and market sentiment before entering.

EPAM stock is predicted to reach $245 in 2025, driven by improving demand in IT services and strong analyst consensus. The stock currently trades at $190.41, with technical indicators suggesting potential upside. Analysts maintain a "Buy" rating with an average price target of $260, indicating confidence in its growth prospects.

The S1 support level for EPAM Stock is $182.4 ,The R1 resistant level for EPAM Stock is $204.16.

As of the end of day on 2025-03-17, the price of EPAM Stock was $181.66.

The target price for EPAM Stock according to analyst rating is 267.91, with the highest price target at 290.00 and the lowest at 235.00. Analysts have a Strong Buy rating on EPAM Stock overall.

The market cap of EPAM is $10.4B.

EPAM may be overvalued based on its high valuation metrics and underperformance. Its P/E ratio of 26.63 and EV/EBITDA of 14.1 are higher than industry averages, suggesting a premium price. The stock has declined 30.3% in the past year, underperforming the S&P 500. While analysts maintain a "Moderate Buy" consensus with a 24-42.5% upside, insider selling and mixed sentiment indicate caution.

EPAM Systems, Inc. is a provider of digital engineering, cloud, and artificial intelligence-enabled transformation services. The Company’s software product and platform development services including product research, customer experience design and prototyping, program management, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, managed services, as well as cross-platform migration and modernizing legacy platforms. The Company operates through three segments: North America, Europe, and Russia. It offers complex software product development services to address the constant need for innovation and agility among software and technology companies. The Company partner with global pharmaceutical, medical and scientific technology, biotechnology companies and retail pharmacies to deliver sophisticated scientific informatics and enterprise technology solutions.

EPAM stock is predicted to reach $300-$350 by 2030, driven by strong earnings growth and a "Moderate Buy" consensus with a mean price target of $260.94, indicating significant upside potential. The company's expansion into AI and digital transformation positions it well for long-term growth.

EPAM has a total of 53150 employees.